Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bills To Speed Generic Entry Once Again Clear Senate Judiciary Committee

Jul 29 2021

• By Brenda Sandburg

US Congress building — Senate Judiciary Committee advances bills to decrease prescription drug costs • Source: Alamy

Related Content

US FDA’s ‘Active Moiety’ Approach On NCE Exclusivity Codified Under Drug Pricing Legislation

Apr 30 2021

Shire's Citizen Petitions Too Old For FTC Action; Door Left Open For Amended Suit

Mar 27 2018

Legal News: Teva V. FDA, Pay-For-Delay, Citizen Petitions, User Fee Scheme

Mar 01 2019

Patent Thicketing Provision Cut From Bill Passed By US Senate Judiciary Committee

Jun 28 2019

Brand-Generic Pay-For-Delay Deals May Become Extinct, FTC Finds

May 23 2019

Pharma Mergers May Have Tougher Time Clearing FTC Under New Review Scheme

Mar 17 2021

Importation, Pay-For-Delay Reform Backed By Biden Order; March-In Rights For Pricing Suggested

Jul 12 2021

US FTC Removing ‘Handcuffs’ To Pursue Pharma Companies, PBMs For Antitrust Violations

Jul 06 2021

Related Companies

Shire Pharmaceuticals Group PLC

Additional Topics

United States Legislation Pricing Debate Intellectual Property Policy Generic Drugs Politics BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window